| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| AMGN - Amgen Inc | BUY | 476 @ USD 323.66 | USD 154,062 | The ETF bought 476 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 323.66 compared to the previous average buy price of 288.162. This is 12.3% higher than average price of previous purchases of AMGN. |
| VRTX - Vertex Pharmaceuticals Inc | BUY | 350 @ USD 421.2 | USD 147,420 | The ETF bought 350 new shares of VRTX (Vertex Pharmaceuticals Inc). The shares were bought for an average price of 421.2 compared to the previous average buy price of 439.131. This is -4.1% lower than average price of previous purchases of VRTX. |
| GILD - Guild Esports Plc | BUY | 1,213 @ USD 118.15 | USD 143,316 | The ETF bought 1213 new shares of GILD (Guild Esports Plc). The shares were bought for an average price of 118.15 compared to the previous average buy price of 112.041. This is 5.5% higher than average price of previous purchases of GILD. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 171 @ USD 654.74 | USD 111,961 | The ETF bought 171 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 654.74 compared to the previous average buy price of 627.339. This is 4.4% higher than average price of previous purchases of REGN. |
| ALNY - Alnylam Pharmaceuticals Inc | BUY | 215 @ USD 441.7 | USD 94,966 | The ETF bought 215 new shares of ALNY (Alnylam Pharmaceuticals Inc). The shares were bought for an average price of 441.7 compared to the previous average buy price of 356.611. This is 23.9% higher than average price of previous purchases of ALNY. |
| AZN - AstraZeneca PLC | BUY | 857 @ USD 87.48 | USD 74,970 | The ETF bought 857 new shares of AZN (AstraZeneca PLC). The shares were bought for an average price of 87.48 compared to the previous average buy price of 74.4108. This is 17.6% higher than average price of previous purchases of AZN. |
| INSM - Insmed Inc | BUY | 350 @ USD 191.92 | USD 67,172 | The ETF bought 350 new shares of INSM (Insmed Inc). The shares were bought for an average price of 191.92 compared to the previous average buy price of 113.845. This is 68.6% higher than average price of previous purchases of INSM. |
| ARGX - argenx NV ADR | BUY | 51 @ USD 869.83 | USD 44,361 | The ETF bought 51 new shares of ARGX (argenx NV ADR). The shares were bought for an average price of 869.83 compared to the previous average buy price of 634.553. This is 37.1% higher than average price of previous purchases of ARGX. |
| BIIB - Biogen Inc | BUY | 243 @ USD 156.26 | USD 37,971 | The ETF bought 243 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 156.26 compared to the previous average buy price of 137.903. This is 13.3% higher than average price of previous purchases of BIIB. |
| INCY - Incyte Corporation | BUY | 324 @ USD 105.98 | USD 34,338 | The ETF bought 324 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 105.98 compared to the previous average buy price of 73.2088. This is 44.8% higher than average price of previous purchases of INCY. |
| UTHR - United Therapeutics Corporation | BUY | 75 @ USD 453.93 | USD 34,045 | The ETF bought 75 new shares of UTHR (United Therapeutics Corporation). The shares were bought for an average price of 453.93 compared to the previous average buy price of 341.856. This is 32.8% higher than average price of previous purchases of UTHR. |
| ILMN - Illumina Inc | BUY | 254 @ USD 121.72 | USD 30,917 | The ETF bought 254 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 121.72 compared to the previous average buy price of 96.3187. This is 26.4% higher than average price of previous purchases of ILMN. |
| MEDP - Medpace Holdings Inc | BUY | 47 @ USD 600.44 | USD 28,221 | The ETF bought 47 new shares of MEDP (Medpace Holdings Inc). The shares were bought for an average price of 600.44 compared to the previous average buy price of 387.722. This is 54.9% higher than average price of previous purchases of MEDP. |
| RPRX - Royalty Pharma Plc | BUY | 714 @ USD 38.54 | USD 27,518 | The ETF bought 714 new shares of RPRX (Royalty Pharma Plc). The shares were bought for an average price of 38.54 compared to the previous average buy price of 35.4226. This is 8.8% higher than average price of previous purchases of RPRX. |
| NBIX - Neurocrine Biosciences Inc | BUY | 164 @ USD 150.02 | USD 24,603 | The ETF bought 164 new shares of NBIX (Neurocrine Biosciences Inc). The shares were bought for an average price of 150.02 compared to the previous average buy price of 129.232. This is 16.1% higher than average price of previous purchases of NBIX. |
| ROIV - Roivant Sciences Ltd | BUY | 1,128 @ USD 21.17 | USD 23,880 | The ETF bought 1128 new shares of ROIV (Roivant Sciences Ltd). The shares were bought for an average price of 21.17 compared to the previous average buy price of 12.7263. This is 66.3% higher than average price of previous purchases of ROIV. |
| SMMT - Summit Therapeutics PLC | BUY | 1,232 @ USD 18.3 | USD 22,546 | The ETF bought 1232 new shares of SMMT (Summit Therapeutics PLC). The shares were bought for an average price of 18.3 compared to the previous average buy price of 21.3588. This is -14.3% lower than average price of previous purchases of SMMT. |
| SNY - Sanofi ADR | BUY | 445 @ USD 50.66 | USD 22,544 | The ETF bought 445 new shares of SNY (Sanofi ADR). The shares were bought for an average price of 50.66 compared to the previous average buy price of 50.0044. This is 1.3% higher than average price of previous purchases of SNY. |
| GH - Guardant Health Inc | BUY | 207 @ USD 97.92 | USD 20,269 | The ETF bought 207 new shares of GH (Guardant Health Inc). The shares were bought for an average price of 97.92 compared to the previous average buy price of 54.3663. This is 80.1% higher than average price of previous purchases of GH. |
| BBIO - BridgeBio Pharma Inc | BUY | 317 @ USD 62.81 | USD 19,911 | The ETF bought 317 new shares of BBIO (BridgeBio Pharma Inc). The shares were bought for an average price of 62.81 compared to the previous average buy price of 44.1594. This is 42.2% higher than average price of previous purchases of BBIO. |
| ASND - Ascendis Pharma AS | BUY | 101 @ USD 196.01 | USD 19,797 | The ETF bought 101 new shares of ASND (Ascendis Pharma AS). The shares were bought for an average price of 196.01 compared to the previous average buy price of 177.391. This is 10.5% higher than average price of previous purchases of ASND. |
| VTRS - Viatris Inc | BUY | 1,935 @ USD 10.17 | USD 19,679 | The ETF bought 1935 new shares of VTRS (Viatris Inc). The shares were bought for an average price of 10.17 compared to the previous average buy price of 9.5689. This is 6.3% higher than average price of previous purchases of VTRS. |
| RVMD - Revolution Medicines Inc | BUY | 310 @ USD 62.73 | USD 19,446 | The ETF bought 310 new shares of RVMD (Revolution Medicines Inc). The shares were bought for an average price of 62.73 compared to the previous average buy price of 41.084. This is 52.7% higher than average price of previous purchases of RVMD. |
| IONS - Ionis Pharmaceuticals Inc | BUY | 265 @ USD 69.54 | USD 18,428 | The ETF bought 265 new shares of IONS (Ionis Pharmaceuticals Inc). The shares were bought for an average price of 69.54 compared to the previous average buy price of 47.7228. This is 45.7% higher than average price of previous purchases of IONS. |
| EXEL - Exelixis Inc | BUY | 445 @ USD 41.41 | USD 18,427 | The ETF bought 445 new shares of EXEL (Exelixis Inc). The shares were bought for an average price of 41.41 compared to the previous average buy price of 40.939. This is 1.2% higher than average price of previous purchases of EXEL. |
| MDGL - Madrigal Pharmaceuticals Inc | BUY | 37 @ USD 495.88 | USD 18,348 | The ETF bought 37 new shares of MDGL (Madrigal Pharmaceuticals Inc). The shares were bought for an average price of 495.88 compared to the previous average buy price of 344.622. This is 43.9% higher than average price of previous purchases of MDGL. |
| BNTX - BioNTech SE | BUY | 166 @ USD 105.07 | USD 17,442 | The ETF bought 166 new shares of BNTX (BioNTech SE). The shares were bought for an average price of 105.07 compared to the previous average buy price of 105.061. This is 0.0% higher than average price of previous purchases of BNTX. |
| BMRN - Biomarin Pharmaceutical Inc | BUY | 317 @ USD 52.67 | USD 16,696 | The ETF bought 317 new shares of BMRN (Biomarin Pharmaceutical Inc). The shares were bought for an average price of 52.67 compared to the previous average buy price of 58.3018. This is -9.7% lower than average price of previous purchases of BMRN. |
| MRNA - Moderna Inc | BUY | 643 @ USD 24.76 | USD 15,921 | The ETF bought 643 new shares of MRNA (Moderna Inc). The shares were bought for an average price of 24.76 compared to the previous average buy price of 29.1568. This is -15.1% lower than average price of previous purchases of MRNA. |
| RNA - Avidity Biosciences Inc | BUY | 213 @ USD 69.84 | USD 14,876 | The ETF bought 213 new shares of RNA (Avidity Biosciences Inc). The shares were bought for an average price of 69.84 compared to the previous average buy price of 36.0992. This is 93.5% higher than average price of previous purchases of RNA. |
| JAZZ - Jazz Pharmaceuticals PLC | BUY | 100 @ USD 133.19 | USD 13,319 | The ETF bought 100 new shares of JAZZ (Jazz Pharmaceuticals PLC). The shares were bought for an average price of 133.19 compared to the previous average buy price of 121.521. This is 9.6% higher than average price of previous purchases of JAZZ. |
| HALO - Halozyme Therapeutics Inc | BUY | 193 @ USD 68.01 | USD 13,126 | The ETF bought 193 new shares of HALO (Halozyme Therapeutics Inc). The shares were bought for an average price of 68.01 compared to the previous average buy price of 59.5675. This is 14.2% higher than average price of previous purchases of HALO. |
| CYTK - Cytokinetics Inc | BUY | 198 @ USD 62.2 | USD 12,316 | The ETF bought 198 new shares of CYTK (Cytokinetics Inc). The shares were bought for an average price of 62.2 compared to the previous average buy price of 42.4275. This is 46.6% higher than average price of previous purchases of CYTK. |
| MRUS - Merus BV | BUY | 125 @ USD 95.42 | USD 11,928 | The ETF bought 125 new shares of MRUS (Merus BV). The shares were bought for an average price of 95.42 compared to the previous average buy price of 62.909. This is 51.7% higher than average price of previous purchases of MRUS. |
| AXSM - Axsome Therapeutics Inc | BUY | 82 @ USD 137.8 | USD 11,300 | The ETF bought 82 new shares of AXSM (Axsome Therapeutics Inc). The shares were bought for an average price of 137.8 compared to the previous average buy price of 114.398. This is 20.5% higher than average price of previous purchases of AXSM. |
| RYTM - Rhythm Pharmaceuticals Inc | BUY | 110 @ USD 97.63 | USD 10,739 | The ETF bought 110 new shares of RYTM (Rhythm Pharmaceuticals Inc). The shares were bought for an average price of 97.63 compared to the previous average buy price of 75.0955. This is 30.0% higher than average price of previous purchases of RYTM. |
| NUVL - Nuvalent Inc | BUY | 110 @ USD 92.98 | USD 10,228 | The ETF bought 110 new shares of NUVL (Nuvalent Inc). The shares were bought for an average price of 92.98 compared to the previous average buy price of 81.7397. This is 13.8% higher than average price of previous purchases of NUVL. |
| KRYS - Krystal Biotech Inc | BUY | 48 @ USD 199.53 | USD 9,577 | The ETF bought 48 new shares of KRYS (Krystal Biotech Inc). The shares were bought for an average price of 199.53 compared to the previous average buy price of 159.904. This is 24.8% higher than average price of previous purchases of KRYS. |
| PTCT - PTC Therapeutics Inc | BUY | 132 @ USD 72.48 | USD 9,567 | The ETF bought 132 new shares of PTCT (PTC Therapeutics Inc). The shares were bought for an average price of 72.48 compared to the previous average buy price of 54.5161. This is 33.0% higher than average price of previous purchases of PTCT. |
| PCVX - Vaxcyte Inc | BUY | 215 @ USD 42.92 | USD 9,228 | The ETF bought 215 new shares of PCVX (Vaxcyte Inc). The shares were bought for an average price of 42.92 compared to the previous average buy price of 44.7265. This is -4.0% lower than average price of previous purchases of PCVX. |
| ARWR - Arrowhead Pharmaceuticals Inc | BUY | 229 @ USD 39.85 | USD 9,126 | The ETF bought 229 new shares of ARWR (Arrowhead Pharmaceuticals Inc). The shares were bought for an average price of 39.85 compared to the previous average buy price of 20.9353. This is 90.3% higher than average price of previous purchases of ARWR. |
| ALKS - Alkermes Plc | BUY | 273 @ USD 32.65 | USD 8,913 | The ETF bought 273 new shares of ALKS (Alkermes Plc). The shares were bought for an average price of 32.65 compared to the previous average buy price of 30.4206. This is 7.3% higher than average price of previous purchases of ALKS. |
| PTGX - Protagonist Therapeutics Inc | BUY | 103 @ USD 83.23 | USD 8,573 | The ETF bought 103 new shares of PTGX (Protagonist Therapeutics Inc). The shares were bought for an average price of 83.23 compared to the previous average buy price of 56.0396. This is 48.5% higher than average price of previous purchases of PTGX. |
| CRSP - Crispr Therapeutics AG | BUY | 150 @ USD 54.58 | USD 8,187 | The ETF bought 150 new shares of CRSP (Crispr Therapeutics AG). The shares were bought for an average price of 54.58 compared to the previous average buy price of 52.3425. This is 4.3% higher than average price of previous purchases of CRSP. |
| ACLX - Arcellx Inc | BUY | 92 @ USD 85.69 | USD 7,883 | The ETF bought 92 new shares of ACLX (Arcellx Inc). The shares were bought for an average price of 85.69 compared to the previous average buy price of 71.6817. This is 19.5% higher than average price of previous purchases of ACLX. |
| KYMR - Kymera Therapeutics Inc | BUY | 119 @ USD 61.26 | USD 7,290 | The ETF bought 119 new shares of KYMR (Kymera Therapeutics Inc). The shares were bought for an average price of 61.26 compared to the previous average buy price of 45.7331. This is 34.0% higher than average price of previous purchases of KYMR. |
| AKRO - Akero Therapeutics Inc | BUY | 133 @ USD 54.14 | USD 7,201 | The ETF bought 133 new shares of AKRO (Akero Therapeutics Inc). The shares were bought for an average price of 54.14 compared to the previous average buy price of 49.2183. This is 10.0% higher than average price of previous purchases of AKRO. |
| LGND - Ligand Pharmaceuticals Incorporated | BUY | 33 @ USD 209.29 | USD 6,907 | The ETF bought 33 new shares of LGND (Ligand Pharmaceuticals Incorporated). The shares were bought for an average price of 209.29 compared to the previous average buy price of 131.708. This is 58.9% higher than average price of previous purchases of LGND. |
| IMVT - Immunovant Inc | BUY | 291 @ USD 23.37 | USD 6,801 | The ETF bought 291 new shares of IMVT (Immunovant Inc). The shares were bought for an average price of 23.37 compared to the previous average buy price of 17.9316. This is 30.3% higher than average price of previous purchases of IMVT. |
| CRNX - Crinetics Pharmaceuticals Inc | BUY | 156 @ USD 41.45 | USD 6,466 | The ETF bought 156 new shares of CRNX (Crinetics Pharmaceuticals Inc). The shares were bought for an average price of 41.45 compared to the previous average buy price of 34.9142. This is 18.7% higher than average price of previous purchases of CRNX. |
| ACAD - ACADIA Pharmaceuticals Inc | BUY | 281 @ USD 22.2 | USD 6,238 | The ETF bought 281 new shares of ACAD (ACADIA Pharmaceuticals Inc). The shares were bought for an average price of 22.2 compared to the previous average buy price of 20.7824. This is 6.8% higher than average price of previous purchases of ACAD. |
| AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock | BUY | 525 @ USD 11.48 | USD 6,027 | The ETF bought 525 new shares of AMRX (Amneal Pharmaceuticals, Inc. Class A Common Stock). The shares were bought for an average price of 11.48 compared to the previous average buy price of 8.75668. This is 31.1% higher than average price of previous purchases of AMRX. |
| PRAX - Praxis Precision Medicines Inc | BUY | 35 @ USD 167.89 | USD 5,876 | The ETF bought 35 new shares of PRAX (Praxis Precision Medicines Inc). The shares were bought for an average price of 167.89 compared to the previous average buy price of 60.0993. This is 179.4% higher than average price of previous purchases of PRAX. |
| MIRM - Mirum Pharmaceuticals Inc | BUY | 84 @ USD 69.71 | USD 5,856 | The ETF bought 84 new shares of MIRM (Mirum Pharmaceuticals Inc). The shares were bought for an average price of 69.71 compared to the previous average buy price of 55.2082. This is 26.3% higher than average price of previous purchases of MIRM. |
| ADMA - ADMA Biologics Inc | BUY | 398 @ USD 14.71 | USD 5,855 | The ETF bought 398 new shares of ADMA (ADMA Biologics Inc). The shares were bought for an average price of 14.71 compared to the previous average buy price of 17.3935. This is -15.4% lower than average price of previous purchases of ADMA. |
| VCYT - Veracyte Inc | BUY | 132 @ USD 42.35 | USD 5,590 | The ETF bought 132 new shares of VCYT (Veracyte Inc). The shares were bought for an average price of 42.35 compared to the previous average buy price of 31.1381. This is 36.0% higher than average price of previous purchases of VCYT. |
| RARE - Ultragenyx | BUY | 161 @ USD 31.94 | USD 5,142 | The ETF bought 161 new shares of RARE (Ultragenyx). The shares were bought for an average price of 31.94 compared to the previous average buy price of 36.5596. This is -12.6% lower than average price of previous purchases of RARE. |
| RARE - WISETFWTMRARETFP | BUY | 161 @ USD 31.94 | USD 5,142 | The ETF bought 161 new shares of RARE (WISETFWTMRARETFP). The shares were bought for an average price of 31.94 compared to the previous average buy price of 36.5596. This is -12.6% lower than average price of previous purchases of RARE. |
| CGON - CG Oncology, Inc. Common stock | BUY | 127 @ USD 40.22 | USD 5,108 | The ETF bought 127 new shares of CGON (CG Oncology, Inc. Common stock). The shares were bought for an average price of 40.22 compared to the previous average buy price of 29.809. This is 34.9% higher than average price of previous purchases of CGON. |
| GRAL - GRAIL, LLC | BUY | 60 @ USD 85.11 | USD 5,107 | The ETF bought 60 new shares of GRAL (GRAIL, LLC). The shares were bought for an average price of 85.11 compared to the previous average buy price of 52.1574. This is 63.2% higher than average price of previous purchases of GRAL. |
| TARS - Tarsus Pharmaceuticals Inc | BUY | 70 @ USD 72.79 | USD 5,095 | The ETF bought 70 new shares of TARS (Tarsus Pharmaceuticals Inc). The shares were bought for an average price of 72.79 compared to the previous average buy price of 48.764. This is 49.3% higher than average price of previous purchases of TARS. |
| TVTX - Travere Therapeutics Inc | BUY | 146 @ USD 34.38 | USD 5,019 | The ETF bought 146 new shares of TVTX (Travere Therapeutics Inc). The shares were bought for an average price of 34.38 compared to the previous average buy price of 19.5465. This is 75.9% higher than average price of previous purchases of TVTX. |
| XENE - Xenon Pharmaceuticals Inc | BUY | 129 @ USD 38.41 | USD 4,955 | The ETF bought 129 new shares of XENE (Xenon Pharmaceuticals Inc). The shares were bought for an average price of 38.41 compared to the previous average buy price of 35.5575. This is 8.0% higher than average price of previous purchases of XENE. |
| MLYS - Mineralys Therapeutics, Inc. Common Stock | BUY | 109 @ USD 44.5 | USD 4,851 | The ETF bought 109 new shares of MLYS (Mineralys Therapeutics, Inc. Common Stock). The shares were bought for an average price of 44.5 compared to the previous average buy price of 19.4249. This is 129.1% higher than average price of previous purchases of MLYS. |
| IRON - Ironveld Plc | BUY | 58 @ USD 83.58 | USD 4,848 | The ETF bought 58 new shares of IRON (Ironveld Plc). The shares were bought for an average price of 83.58 compared to the previous average buy price of 58.4084. This is 43.1% higher than average price of previous purchases of IRON. |
| SRRK - Scholar Rock Holding Corp | BUY | 160 @ USD 29.37 | USD 4,699 | The ETF bought 160 new shares of SRRK (Scholar Rock Holding Corp). The shares were bought for an average price of 29.37 compared to the previous average buy price of 34.959. This is -16.0% lower than average price of previous purchases of SRRK. |
| ARQT - Arcutis Biotherapeutics Inc | BUY | 197 @ USD 23.75 | USD 4,679 | The ETF bought 197 new shares of ARQT (Arcutis Biotherapeutics Inc). The shares were bought for an average price of 23.75 compared to the previous average buy price of 16.0714. This is 47.8% higher than average price of previous purchases of ARQT. |
| FOLD - Amicus Therapeutics Inc | BUY | 507 @ USD 9 | USD 4,563 | The ETF bought 507 new shares of FOLD (Amicus Therapeutics Inc). The shares were bought for an average price of 9 compared to the previous average buy price of 7.33773. This is 22.7% higher than average price of previous purchases of FOLD. |
| IDYA - Ideaya Biosciences Inc | BUY | 147 @ USD 30.89 | USD 4,541 | The ETF bought 147 new shares of IDYA (Ideaya Biosciences Inc). The shares were bought for an average price of 30.89 compared to the previous average buy price of 23.1332. This is 33.5% higher than average price of previous purchases of IDYA. |
| DYN - Dyne Therapeutics Inc | BUY | 238 @ USD 18.51 | USD 4,405 | The ETF bought 238 new shares of DYN (Dyne Therapeutics Inc). The shares were bought for an average price of 18.51 compared to the previous average buy price of 12.6915. This is 45.8% higher than average price of previous purchases of DYN. |
| DYN - DYNAGREEN EN.PR.GR.H YC 1 | BUY | 238 @ USD 18.51 | USD 4,405 | The ETF bought 238 new shares of DYN (DYNAGREEN EN.PR.GR.H YC 1). The shares were bought for an average price of 18.51 compared to the previous average buy price of 12.6915. This is 45.8% higher than average price of previous purchases of DYN. |
| LEGN - Legend Biotech Corp | BUY | 139 @ USD 31.59 | USD 4,391 | The ETF bought 139 new shares of LEGN (Legend Biotech Corp). The shares were bought for an average price of 31.59 compared to the previous average buy price of 34.6859. This is -8.9% lower than average price of previous purchases of LEGN. |
| APGE - Apogee Therapeutics, Inc. Common Stock | BUY | 76 @ USD 56.77 | USD 4,315 | The ETF bought 76 new shares of APGE (Apogee Therapeutics, Inc. Common Stock). The shares were bought for an average price of 56.77 compared to the previous average buy price of 43.5168. This is 30.5% higher than average price of previous purchases of APGE. |
| SUPN - Supernus Pharmaceuticals Inc | BUY | 94 @ USD 45.4 | USD 4,268 | The ETF bought 94 new shares of SUPN (Supernus Pharmaceuticals Inc). The shares were bought for an average price of 45.4 compared to the previous average buy price of 37.4665. This is 21.2% higher than average price of previous purchases of SUPN. |
| APLS - Apellis Pharmaceuticals Inc | BUY | 211 @ USD 19 | USD 4,009 | The ETF bought 211 new shares of APLS (Apellis Pharmaceuticals Inc). The shares were bought for an average price of 19 compared to the previous average buy price of 21.1104. This is -10.0% lower than average price of previous purchases of APLS. |
| AGIO - Agios Pharm | BUY | 95 @ USD 41.38 | USD 3,931 | The ETF bought 95 new shares of AGIO (Agios Pharm). The shares were bought for an average price of 41.38 compared to the previous average buy price of 35.7468. This is 15.8% higher than average price of previous purchases of AGIO. |
| DNLI - Denali Therapeutics Inc | BUY | 240 @ USD 15.6 | USD 3,744 | The ETF bought 240 new shares of DNLI (Denali Therapeutics Inc). The shares were bought for an average price of 15.6 compared to the previous average buy price of 15.1282. This is 3.1% higher than average price of previous purchases of DNLI. |
| ADPT - Adaptive Biotechnologies Corp | BUY | 250 @ USD 14.71 | USD 3,678 | The ETF bought 250 new shares of ADPT (Adaptive Biotechnologies Corp). The shares were bought for an average price of 14.71 compared to the previous average buy price of 11.841. This is 24.2% higher than average price of previous purchases of ADPT. |
| BEAM - Beam Therapeutics Inc | BUY | 166 @ USD 21.65 | USD 3,594 | The ETF bought 166 new shares of BEAM (Beam Therapeutics Inc). The shares were bought for an average price of 21.65 compared to the previous average buy price of 20.557. This is 5.3% higher than average price of previous purchases of BEAM. |
| CNTA - Centessa Pharmaceuticals PLC ADR | BUY | 158 @ USD 22.33 | USD 3,528 | The ETF bought 158 new shares of CNTA (Centessa Pharmaceuticals PLC ADR). The shares were bought for an average price of 22.33 compared to the previous average buy price of 16.3476. This is 36.6% higher than average price of previous purchases of CNTA. |
| IBRX - Immunitybio Inc | BUY | 1,580 @ USD 2.16 | USD 3,413 | The ETF bought 1580 new shares of IBRX (Immunitybio Inc). The shares were bought for an average price of 2.16 compared to the previous average buy price of 2.77166. This is -22.1% lower than average price of previous purchases of IBRX. |
| GPCR - Structure Therapeutics Inc. American Depositary Shares | BUY | 98 @ USD 33.9 | USD 3,322 | The ETF bought 98 new shares of GPCR (Structure Therapeutics Inc. American Depositary Shares). The shares were bought for an average price of 33.9 compared to the previous average buy price of 22.942. This is 47.8% higher than average price of previous purchases of GPCR. |
| TXG - 10X Genomics Inc | BUY | 190 @ USD 17.08 | USD 3,245 | The ETF bought 190 new shares of TXG (10X Genomics Inc). The shares were bought for an average price of 17.08 compared to the previous average buy price of 11.9918. This is 42.4% higher than average price of previous purchases of TXG. |
| TXG - Terex Corporation | BUY | 190 @ USD 17.08 | USD 3,245 | The ETF bought 190 new shares of TXG (Terex Corporation). The shares were bought for an average price of 17.08 compared to the previous average buy price of 11.9918. This is 42.4% higher than average price of previous purchases of TXG. |
| VCEL - Vericel Corp Ord | BUY | 83 @ USD 38.99 | USD 3,236 | The ETF bought 83 new shares of VCEL (Vericel Corp Ord). The shares were bought for an average price of 38.99 compared to the previous average buy price of 40.8333. This is -4.5% lower than average price of previous purchases of VCEL. |
| RXRX - Recursion Pharmaceuticals Inc | BUY | 717 @ USD 4.51 | USD 3,234 | The ETF bought 717 new shares of RXRX (Recursion Pharmaceuticals Inc). The shares were bought for an average price of 4.51 compared to the previous average buy price of 5.7985. This is -22.2% lower than average price of previous purchases of RXRX. |
| AUPH - Aurinia Pharmaceuticals Inc | BUY | 217 @ USD 14.89 | USD 3,231 | The ETF bought 217 new shares of AUPH (Aurinia Pharmaceuticals Inc). The shares were bought for an average price of 14.89 compared to the previous average buy price of 9.03759. This is 64.8% higher than average price of previous purchases of AUPH. |
| ANIP - ANI Pharmaceuticals Inc | BUY | 36 @ USD 88.93 | USD 3,201 | The ETF bought 36 new shares of ANIP (ANI Pharmaceuticals Inc). The shares were bought for an average price of 88.93 compared to the previous average buy price of 72.4067. This is 22.8% higher than average price of previous purchases of ANIP. |
| EWTX - Edgewise Therapeutics Inc | BUY | 173 @ USD 18.28 | USD 3,162 | The ETF bought 173 new shares of EWTX (Edgewise Therapeutics Inc). The shares were bought for an average price of 18.28 compared to the previous average buy price of 15.827. This is 15.5% higher than average price of previous purchases of EWTX. |
| OCUL - Ocular Therapeutix Inc | BUY | 286 @ USD 10.83 | USD 3,097 | The ETF bought 286 new shares of OCUL (Ocular Therapeutix Inc). The shares were bought for an average price of 10.83 compared to the previous average buy price of 9.60211. This is 12.8% higher than average price of previous purchases of OCUL. |
| TWST - Twist Bioscience Corp | BUY | 99 @ USD 30.96 | USD 3,065 | The ETF bought 99 new shares of TWST (Twist Bioscience Corp). The shares were bought for an average price of 30.96 compared to the previous average buy price of 36.4329. This is -15.0% lower than average price of previous purchases of TWST. |
| AVDL - Avadel Pharmaceuticals PLC | BUY | 160 @ USD 18.7 | USD 2,992 | The ETF bought 160 new shares of AVDL (Avadel Pharmaceuticals PLC). The shares were bought for an average price of 18.7 compared to the previous average buy price of 10.7616. This is 73.8% higher than average price of previous purchases of AVDL. |
| HRMY - Harmony Biosciences Holdings | BUY | 94 @ USD 31.82 | USD 2,991 | The ETF bought 94 new shares of HRMY (Harmony Biosciences Holdings). The shares were bought for an average price of 31.82 compared to the previous average buy price of 31.7344. This is 0.3% higher than average price of previous purchases of HRMY. |
| VERA - Vera Therapeutics Inc | BUY | 105 @ USD 27.75 | USD 2,914 | The ETF bought 105 new shares of VERA (Vera Therapeutics Inc). The shares were bought for an average price of 27.75 compared to the previous average buy price of 26.9141. This is 3.1% higher than average price of previous purchases of VERA. |
| KNSA - Kiniksa Pharmaceuticals Ltd | BUY | 72 @ USD 39.5 | USD 2,844 | The ETF bought 72 new shares of KNSA (Kiniksa Pharmaceuticals Ltd). The shares were bought for an average price of 39.5 compared to the previous average buy price of 29.5811. This is 33.5% higher than average price of previous purchases of KNSA. |
| SRPT - Sarepta Therapeutics Inc | BUY | 161 @ USD 17.27 | USD 2,780 | The ETF bought 161 new shares of SRPT (Sarepta Therapeutics Inc). The shares were bought for an average price of 17.27 compared to the previous average buy price of 34.6821. This is -50.2% lower than average price of previous purchases of SRPT. |
| TERN - Tern Plc | BUY | 144 @ USD 19.12 | USD 2,753 | The ETF bought 144 new shares of TERN (Tern Plc). The shares were bought for an average price of 19.12 compared to the previous average buy price of 5.24813. This is 264.3% higher than average price of previous purchases of TERN. |
| MNKD - MannKind Corp | BUY | 506 @ USD 5.42 | USD 2,743 | The ETF bought 506 new shares of MNKD (MannKind Corp). The shares were bought for an average price of 5.42 compared to the previous average buy price of 4.73822. This is 14.4% higher than average price of previous purchases of MNKD. |
| JANX - Janux Therapeutics Inc | BUY | 99 @ USD 27.59 | USD 2,731 | The ETF bought 99 new shares of JANX (Janux Therapeutics Inc). The shares were bought for an average price of 27.59 compared to the previous average buy price of 27.7163. This is -0.5% lower than average price of previous purchases of JANX. |
| BCRX - BioCryst Pharmaceuticals Inc | BUY | 346 @ USD 7.2 | USD 2,491 | The ETF bought 346 new shares of BCRX (BioCryst Pharmaceuticals Inc). The shares were bought for an average price of 7.2 compared to the previous average buy price of 8.3353. This is -13.6% lower than average price of previous purchases of BCRX. |
| QURE - Uniqure NV | BUY | 91 @ USD 26.15 | USD 2,380 | The ETF bought 91 new shares of QURE (Uniqure NV). The shares were bought for an average price of 26.15 compared to the previous average buy price of 23.0704. This is 13.3% higher than average price of previous purchases of QURE. |
| IMCR - Immunocore Holdings Ltd | BUY | 67 @ USD 35 | USD 2,345 | The ETF bought 67 new shares of IMCR (Immunocore Holdings Ltd). The shares were bought for an average price of 35 compared to the previous average buy price of 32.6169. This is 7.3% higher than average price of previous purchases of IMCR. |
| ZYME - Zymeworks Inc. Common Stock | BUY | 127 @ USD 18.05 | USD 2,292 | The ETF bought 127 new shares of ZYME (Zymeworks Inc. Common Stock). The shares were bought for an average price of 18.05 compared to the previous average buy price of 14.2548. This is 26.6% higher than average price of previous purchases of ZYME. |
| COLL - Collegium Pharmaceutical Inc | BUY | 52 @ USD 43.53 | USD 2,264 | The ETF bought 52 new shares of COLL (Collegium Pharmaceutical Inc). The shares were bought for an average price of 43.53 compared to the previous average buy price of 31.389. This is 38.7% higher than average price of previous purchases of COLL. |
| ARDX - Ardelyx Inc | BUY | 398 @ USD 5.65 | USD 2,249 | The ETF bought 398 new shares of ARDX (Ardelyx Inc). The shares were bought for an average price of 5.65 compared to the previous average buy price of 4.59538. This is 22.9% higher than average price of previous purchases of ARDX. |
| SNDX - Syndax Pharmaceuticals Inc | BUY | 142 @ USD 15.72 | USD 2,232 | The ETF bought 142 new shares of SNDX (Syndax Pharmaceuticals Inc). The shares were bought for an average price of 15.72 compared to the previous average buy price of 11.5977. This is 35.5% higher than average price of previous purchases of SNDX. |
| SYRE - Spyre Therapeutics Inc. | BUY | 99 @ USD 22.18 | USD 2,196 | The ETF bought 99 new shares of SYRE (Spyre Therapeutics Inc.). The shares were bought for an average price of 22.18 compared to the previous average buy price of 17.3981. This is 27.5% higher than average price of previous purchases of SYRE. |
| INVA - Innoviva Inc | BUY | 103 @ USD 20.87 | USD 2,150 | The ETF bought 103 new shares of INVA (Innoviva Inc). The shares were bought for an average price of 20.87 compared to the previous average buy price of 18.8748. This is 10.6% higher than average price of previous purchases of INVA. |
| DVAX - Dynavax Technologies Corporation | BUY | 194 @ USD 11.04 | USD 2,142 | The ETF bought 194 new shares of DVAX (Dynavax Technologies Corporation). The shares were bought for an average price of 11.04 compared to the previous average buy price of 10.422. This is 5.9% higher than average price of previous purchases of DVAX. |
| XERS - Xeris Pharmaceuticals Inc | BUY | 275 @ USD 7.72 | USD 2,123 | The ETF bought 275 new shares of XERS (Xeris Pharmaceuticals Inc). The shares were bought for an average price of 7.72 compared to the previous average buy price of 6.0538. This is 27.5% higher than average price of previous purchases of XERS. |
| NVCR - Novocure Ltd | BUY | 185 @ USD 11.27 | USD 2,085 | The ETF bought 185 new shares of NVCR (Novocure Ltd). The shares were bought for an average price of 11.27 compared to the previous average buy price of 16.9001. This is -33.3% lower than average price of previous purchases of NVCR. |
| HROW - Harrow Health Inc | BUY | 61 @ USD 34.14 | USD 2,083 | The ETF bought 61 new shares of HROW (Harrow Health Inc). The shares were bought for an average price of 34.14 compared to the previous average buy price of 33.2683. This is 2.6% higher than average price of previous purchases of HROW. |
| STOK - Stoke Therapeutics Inc | BUY | 92 @ USD 22.37 | USD 2,058 | The ETF bought 92 new shares of STOK (Stoke Therapeutics Inc). The shares were bought for an average price of 22.37 compared to the previous average buy price of 15.685. This is 42.6% higher than average price of previous purchases of STOK. |
| PGEN - Precigen Inc | BUY | 504 @ USD 4 | USD 2,016 | The ETF bought 504 new shares of PGEN (Precigen Inc). The shares were bought for an average price of 4 compared to the previous average buy price of 2.24578. This is 78.1% higher than average price of previous purchases of PGEN. |
| GMAB - Genmab AS | BUY | 69 @ USD 29.06 | USD 2,005 | The ETF bought 69 new shares of GMAB (Genmab AS). The shares were bought for an average price of 29.06 compared to the previous average buy price of 23.3088. This is 24.7% higher than average price of previous purchases of GMAB. |
| ORIC - Oric Pharmaceuticals Inc | BUY | 160 @ USD 12.46 | USD 1,994 | The ETF bought 160 new shares of ORIC (Oric Pharmaceuticals Inc). The shares were bought for an average price of 12.46 compared to the previous average buy price of 10.4607. This is 19.1% higher than average price of previous purchases of ORIC. |
| ABCL - Abcellera Biologics Inc | BUY | 494 @ USD 4.03 | USD 1,991 | The ETF bought 494 new shares of ABCL (Abcellera Biologics Inc). The shares were bought for an average price of 4.03 compared to the previous average buy price of 3.90978. This is 3.1% higher than average price of previous purchases of ABCL. |
| AMPH - Amphastar P | BUY | 76 @ USD 26.12 | USD 1,985 | The ETF bought 76 new shares of AMPH (Amphastar P). The shares were bought for an average price of 26.12 compared to the previous average buy price of 25.5803. This is 2.1% higher than average price of previous purchases of AMPH. |
| CVAC - CureVac NV | BUY | 372 @ USD 5.23 | USD 1,946 | The ETF bought 372 new shares of CVAC (CureVac NV). The shares were bought for an average price of 5.23 compared to the previous average buy price of 4.81432. This is 8.6% higher than average price of previous purchases of CVAC. |
| NVAX - Novavax Inc | BUY | 268 @ USD 7.11 | USD 1,905 | The ETF bought 268 new shares of NVAX (Novavax Inc). The shares were bought for an average price of 7.11 compared to the previous average buy price of 7.41065. This is -4.1% lower than average price of previous purchases of NVAX. |
| NVAX - Hana Microelectronics Public Company Limited | BUY | 268 @ USD 7.11 | USD 1,905 | The ETF bought 268 new shares of NVAX (Hana Microelectronics Public Company Limited). The shares were bought for an average price of 7.11 compared to the previous average buy price of 7.41065. This is -4.1% lower than average price of previous purchases of NVAX. |
| WVE - Wave Life Sciences Ltd | BUY | 269 @ USD 7.05 | USD 1,896 | The ETF bought 269 new shares of WVE (Wave Life Sciences Ltd). The shares were bought for an average price of 7.05 compared to the previous average buy price of 8.46992. This is -16.8% lower than average price of previous purchases of WVE. |
| ELVN - Enliven Therapeutics Inc. | BUY | 98 @ USD 18.71 | USD 1,834 | The ETF bought 98 new shares of ELVN (Enliven Therapeutics Inc.). The shares were bought for an average price of 18.71 compared to the previous average buy price of 20.8303. This is -10.2% lower than average price of previous purchases of ELVN. |
| URGN - UroGen Pharma Ltd | BUY | 79 @ USD 23.13 | USD 1,827 | The ETF bought 79 new shares of URGN (UroGen Pharma Ltd). The shares were bought for an average price of 23.13 compared to the previous average buy price of 14.5067. This is 59.4% higher than average price of previous purchases of URGN. |
| SANA - Sana Biotechnology Inc | BUY | 435 @ USD 4.12 | USD 1,792 | The ETF bought 435 new shares of SANA (Sana Biotechnology Inc). The shares were bought for an average price of 4.12 compared to the previous average buy price of 3.14576. This is 31.0% higher than average price of previous purchases of SANA. |
| AMLX - Amylyx Pharmaceuticals Inc | BUY | 147 @ USD 12.18 | USD 1,790 | The ETF bought 147 new shares of AMLX (Amylyx Pharmaceuticals Inc). The shares were bought for an average price of 12.18 compared to the previous average buy price of 6.86127. This is 77.5% higher than average price of previous purchases of AMLX. |
| RLAY - Relay Therapeutics Inc | BUY | 286 @ USD 6.17 | USD 1,765 | The ETF bought 286 new shares of RLAY (Relay Therapeutics Inc). The shares were bought for an average price of 6.17 compared to the previous average buy price of 4.12543. This is 49.6% higher than average price of previous purchases of RLAY. |
| TSHA - Taysha Gene Therapies Inc | BUY | 452 @ USD 3.89 | USD 1,758 | The ETF bought 452 new shares of TSHA (Taysha Gene Therapies Inc). The shares were bought for an average price of 3.89 compared to the previous average buy price of 2.85863. This is 36.1% higher than average price of previous purchases of TSHA. |
| NTLA - Intellia Therapeutics Inc | BUY | 180 @ USD 9.73 | USD 1,751 | The ETF bought 180 new shares of NTLA (Intellia Therapeutics Inc). The shares were bought for an average price of 9.73 compared to the previous average buy price of 12.5091. This is -22.2% lower than average price of previous purchases of NTLA. |
| GRFS - Grifols SA ADR | BUY | 202 @ USD 8.60001 | USD 1,737 | The ETF bought 202 new shares of GRFS (Grifols SA ADR). The shares were bought for an average price of 8.60001 compared to the previous average buy price of 9.40813. This is -8.6% lower than average price of previous purchases of GRFS. |
| ZLAB - Zai Lab Ltd | BUY | 79 @ USD 21.89 | USD 1,729 | The ETF bought 79 new shares of ZLAB (Zai Lab Ltd). The shares were bought for an average price of 21.89 compared to the previous average buy price of 34.1121. This is -35.8% lower than average price of previous purchases of ZLAB. |
| PCRX - Pacira BioSciences, Inc. | BUY | 74 @ USD 23.07 | USD 1,707 | The ETF bought 74 new shares of PCRX (Pacira BioSciences, Inc.). The shares were bought for an average price of 23.07 compared to the previous average buy price of 23.8493. This is -3.3% lower than average price of previous purchases of PCRX. |
| DAWN - Day One Biopharmaceuticals Inc | BUY | 168 @ USD 10.16 | USD 1,707 | The ETF bought 168 new shares of DAWN (Day One Biopharmaceuticals Inc). The shares were bought for an average price of 10.16 compared to the previous average buy price of 7.39484. This is 37.4% higher than average price of previous purchases of DAWN. |
| FTRE - Fortrea Holdings Inc. | BUY | 150 @ USD 11.18 | USD 1,677 | The ETF bought 150 new shares of FTRE (Fortrea Holdings Inc.). The shares were bought for an average price of 11.18 compared to the previous average buy price of 6.60705. This is 69.2% higher than average price of previous purchases of FTRE. |
| CSTL - Castle Biosciences Inc | BUY | 48 @ USD 34.74 | USD 1,668 | The ETF bought 48 new shares of CSTL (Castle Biosciences Inc). The shares were bought for an average price of 34.74 compared to the previous average buy price of 21.5031. This is 61.6% higher than average price of previous purchases of CSTL. |
| PHAT - Phathom Pharmaceuticals Inc | BUY | 120 @ USD 13.73 | USD 1,648 | The ETF bought 120 new shares of PHAT (Phathom Pharmaceuticals Inc). The shares were bought for an average price of 13.73 compared to the previous average buy price of 8.87379. This is 54.7% higher than average price of previous purchases of PHAT. |
| NRIX - Nurix Therapeutics Inc | BUY | 133 @ USD 12.25 | USD 1,629 | The ETF bought 133 new shares of NRIX (Nurix Therapeutics Inc). The shares were bought for an average price of 12.25 compared to the previous average buy price of 12.0458. This is 1.7% higher than average price of previous purchases of NRIX. |
| XNCR - Xencor Inc | BUY | 118 @ USD 13.74 | USD 1,621 | The ETF bought 118 new shares of XNCR (Xencor Inc). The shares were bought for an average price of 13.74 compared to the previous average buy price of 11.1418. This is 23.3% higher than average price of previous purchases of XNCR. |
| ANAB - AnaptysBio Inc | BUY | 46 @ USD 33.98 | USD 1,563 | The ETF bought 46 new shares of ANAB (AnaptysBio Inc). The shares were bought for an average price of 33.98 compared to the previous average buy price of 23.8479. This is 42.5% higher than average price of previous purchases of ANAB. |
| KURA - Kura Oncology Inc | BUY | 150 @ USD 10.32 | USD 1,548 | The ETF bought 150 new shares of KURA (Kura Oncology Inc). The shares were bought for an average price of 10.32 compared to the previous average buy price of 7.21533. This is 43.0% higher than average price of previous purchases of KURA. |
| PAHC - Phibro Animal Health Corporation | BUY | 33 @ USD 45.83 | USD 1,512 | The ETF bought 33 new shares of PAHC (Phibro Animal Health Corporation). The shares were bought for an average price of 45.83 compared to the previous average buy price of 28.2645. This is 62.1% higher than average price of previous purchases of PAHC. |
| MNMD - Mind Medicine Inc | BUY | 128 @ USD 11.75 | USD 1,504 | The ETF bought 128 new shares of MNMD (Mind Medicine Inc). The shares were bought for an average price of 11.75 compared to the previous average buy price of 8.50403. This is 38.2% higher than average price of previous purchases of MNMD. |
| ABUS - Arbutus Biopharma Corp | BUY | 324 @ USD 4.59 | USD 1,487 | The ETF bought 324 new shares of ABUS (Arbutus Biopharma Corp). The shares were bought for an average price of 4.59 compared to the previous average buy price of 3.62433. This is 26.6% higher than average price of previous purchases of ABUS. |
| TNGX - Tango Therapeutics Inc | BUY | 184 @ USD 7.92999 | USD 1,459 | The ETF bought 184 new shares of TNGX (Tango Therapeutics Inc). The shares were bought for an average price of 7.92999 compared to the previous average buy price of 6.1116. This is 29.8% higher than average price of previous purchases of TNGX. |
| SPRY - Silverback Therapeutics Inc | BUY | 162 @ USD 8.88 | USD 1,439 | The ETF bought 162 new shares of SPRY (Silverback Therapeutics Inc). The shares were bought for an average price of 8.88 compared to the previous average buy price of 13.7417. This is -35.4% lower than average price of previous purchases of SPRY. |
| IOVA - Iovance Biotherapeutics Inc | BUY | 589 @ USD 2.37 | USD 1,396 | The ETF bought 589 new shares of IOVA (Iovance Biotherapeutics Inc). The shares were bought for an average price of 2.37 compared to the previous average buy price of 2.43632. This is -2.7% lower than average price of previous purchases of IOVA. |
| ARVN - Arvinas Inc | BUY | 119 @ USD 11.19 | USD 1,332 | The ETF bought 119 new shares of ARVN (Arvinas Inc). The shares were bought for an average price of 11.19 compared to the previous average buy price of 8.7263. This is 28.2% higher than average price of previous purchases of ARVN. |
| EYPT - Eyepoint Pharmaceuticals Inc | BUY | 114 @ USD 11.35 | USD 1,294 | The ETF bought 114 new shares of EYPT (Eyepoint Pharmaceuticals Inc). The shares were bought for an average price of 11.35 compared to the previous average buy price of 8.67824. This is 30.8% higher than average price of previous purchases of EYPT. |
| TBPH - Theravance Biopharma Inc | BUY | 83 @ USD 15.08 | USD 1,252 | The ETF bought 83 new shares of TBPH (Theravance Biopharma Inc). The shares were bought for an average price of 15.08 compared to the previous average buy price of 11.6399. This is 29.6% higher than average price of previous purchases of TBPH. |
| VIR - Vir Biotechnology Inc | BUY | 229 @ USD 5.37 | USD 1,230 | The ETF bought 229 new shares of VIR (Vir Biotechnology Inc). The shares were bought for an average price of 5.37 compared to the previous average buy price of 5.84572. This is -8.1% lower than average price of previous purchases of VIR. |
| VIR - Vidrala S.A | BUY | 229 @ USD 5.37 | USD 1,230 | The ETF bought 229 new shares of VIR (Vidrala S.A). The shares were bought for an average price of 5.37 compared to the previous average buy price of 5.84572. This is -8.1% lower than average price of previous purchases of VIR. |
| GERN - Geron Corporation | BUY | 1,052 @ USD 1.16 | USD 1,220 | The ETF bought 1052 new shares of GERN (Geron Corporation). The shares were bought for an average price of 1.16 compared to the previous average buy price of 1.52831. This is -24.1% lower than average price of previous purchases of GERN. |
| REPL - Replimune Group Inc | BUY | 133 @ USD 8.70999 | USD 1,158 | The ETF bought 133 new shares of REPL (Replimune Group Inc). The shares were bought for an average price of 8.70999 compared to the previous average buy price of 8.93706. This is -2.5% lower than average price of previous purchases of REPL. |
| ERAS - Erasca Inc | BUY | 505 @ USD 2.29 | USD 1,156 | The ETF bought 505 new shares of ERAS (Erasca Inc). The shares were bought for an average price of 2.29 compared to the previous average buy price of 1.63607. This is 40.0% higher than average price of previous purchases of ERAS. |
| MGTX - MeiraGTx Holdings PLC | BUY | 134 @ USD 8.55 | USD 1,146 | The ETF bought 134 new shares of MGTX (MeiraGTx Holdings PLC). The shares were bought for an average price of 8.55 compared to the previous average buy price of 7.16643. This is 19.3% higher than average price of previous purchases of MGTX. |
| SVRA - Savara Inc | BUY | 286 @ USD 4 | USD 1,144 | The ETF bought 286 new shares of SVRA (Savara Inc). The shares were bought for an average price of 4 compared to the previous average buy price of 2.77267. This is 44.3% higher than average price of previous purchases of SVRA. |
| KROS - Keros Therapeutics Inc | BUY | 66 @ USD 17.04 | USD 1,125 | The ETF bought 66 new shares of KROS (Keros Therapeutics Inc). The shares were bought for an average price of 17.04 compared to the previous average buy price of 13.6498. This is 24.8% higher than average price of previous purchases of KROS. |
| PRME - Prime Medicine, Inc. Common Stock | BUY | 291 @ USD 3.525 | USD 1,026 | The ETF bought 291 new shares of PRME (Prime Medicine, Inc. Common Stock). The shares were bought for an average price of 3.525 compared to the previous average buy price of 3.97738. This is -11.4% lower than average price of previous purchases of PRME. |
| OLMA - Olema Pharmaceuticals Inc | BUY | 112 @ USD 8.7 | USD 974 | The ETF bought 112 new shares of OLMA (Olema Pharmaceuticals Inc). The shares were bought for an average price of 8.7 compared to the previous average buy price of 5.49797. This is 58.2% higher than average price of previous purchases of OLMA. |
| RGNX - Regenxbio Inc | BUY | 87 @ USD 11.02 | USD 959 | The ETF bought 87 new shares of RGNX (Regenxbio Inc). The shares were bought for an average price of 11.02 compared to the previous average buy price of 9.12904. This is 20.7% higher than average price of previous purchases of RGNX. |
| PRTA - Prothena Corporation plc | BUY | 91 @ USD 10.53 | USD 958 | The ETF bought 91 new shares of PRTA (Prothena Corporation plc). The shares were bought for an average price of 10.53 compared to the previous average buy price of 9.02717. This is 16.6% higher than average price of previous purchases of PRTA. |
| PACB - Pacific Biosciences of California | BUY | 530 @ USD 1.76 | USD 933 | The ETF bought 530 new shares of PACB (Pacific Biosciences of California). The shares were bought for an average price of 1.76 compared to the previous average buy price of 1.54587. This is 13.9% higher than average price of previous purchases of PACB. |
| AVXL - Anavex Life Sciences Corp | BUY | 143 @ USD 6.49 | USD 928 | The ETF bought 143 new shares of AVXL (Anavex Life Sciences Corp). The shares were bought for an average price of 6.49 compared to the previous average buy price of 9.55786. This is -32.1% lower than average price of previous purchases of AVXL. |
| LXRX - Lexicon Pharmaceuticals Inc | BUY | 634 @ USD 1.42 | USD 900 | The ETF bought 634 new shares of LXRX (Lexicon Pharmaceuticals Inc). The shares were bought for an average price of 1.42 compared to the previous average buy price of 1.03946. This is 36.6% higher than average price of previous purchases of LXRX. |
| KALV - Kalvista Pharmaceuticals Inc | BUY | 82 @ USD 10.89 | USD 893 | The ETF bought 82 new shares of KALV (Kalvista Pharmaceuticals Inc). The shares were bought for an average price of 10.89 compared to the previous average buy price of 12.2548. This is -11.1% lower than average price of previous purchases of KALV. |
| FDMT - 4D Molecular Therapeutics Inc | BUY | 83 @ USD 10.17 | USD 844 | The ETF bought 83 new shares of FDMT (4D Molecular Therapeutics Inc). The shares were bought for an average price of 10.17 compared to the previous average buy price of 6.22508. This is 63.4% higher than average price of previous purchases of FDMT. |
| EOLS - Evolus Inc | BUY | 117 @ USD 7.05 | USD 825 | The ETF bought 117 new shares of EOLS (Evolus Inc). The shares were bought for an average price of 7.05 compared to the previous average buy price of 9.2447. This is -23.7% lower than average price of previous purchases of EOLS. |
| MRVI - Maravai Lifesciences Holdings Inc | BUY | 262 @ USD 3.1 | USD 812 | The ETF bought 262 new shares of MRVI (Maravai Lifesciences Holdings Inc). The shares were bought for an average price of 3.1 compared to the previous average buy price of 2.69314. This is 15.1% higher than average price of previous purchases of MRVI. |
| GLPG - Galapagos NV ADR | BUY | 25 @ USD 32.4501 | USD 811 | The ETF bought 25 new shares of GLPG (Galapagos NV ADR). The shares were bought for an average price of 32.4501 compared to the previous average buy price of 28.9971. This is 11.9% higher than average price of previous purchases of GLPG. |
| GLPG - Galapagos N.V. | BUY | 25 @ USD 32.4501 | USD 811 | The ETF bought 25 new shares of GLPG (Galapagos N.V.). The shares were bought for an average price of 32.4501 compared to the previous average buy price of 28.9971. This is 11.9% higher than average price of previous purchases of GLPG. |
| HCM - HUTCHMED China Ltd | BUY | 53 @ USD 15.085 | USD 800 | The ETF bought 53 new shares of HCM (HUTCHMED China Ltd). The shares were bought for an average price of 15.085 compared to the previous average buy price of 15.4366. This is -2.3% lower than average price of previous purchases of HCM. |
| HCM - Hitachi Construction Machinery Co. Ltd | BUY | 53 @ USD 15.085 | USD 800 | The ETF bought 53 new shares of HCM (Hitachi Construction Machinery Co. Ltd). The shares were bought for an average price of 15.085 compared to the previous average buy price of 15.4366. This is -2.3% lower than average price of previous purchases of HCM. |
| SIGA - SIGA Technologies Inc | BUY | 118 @ USD 6.51001 | USD 768 | The ETF bought 118 new shares of SIGA (SIGA Technologies Inc). The shares were bought for an average price of 6.51001 compared to the previous average buy price of 6.82605. This is -4.6% lower than average price of previous purchases of SIGA. |
| CGEM - Cullinan Oncology LLC | BUY | 102 @ USD 7.44001 | USD 759 | The ETF bought 102 new shares of CGEM (Cullinan Oncology LLC). The shares were bought for an average price of 7.44001 compared to the previous average buy price of 7.8634. This is -5.4% lower than average price of previous purchases of CGEM. |
| ALT - Altitude Group Plc | BUY | 144 @ USD 4.26001 | USD 613 | The ETF bought 144 new shares of ALT (Altitude Group Plc). The shares were bought for an average price of 4.26001 compared to the previous average buy price of 5.27691. This is -19.3% lower than average price of previous purchases of ALT. |
| RCKT - Rocket Pharmaceuticals Inc | BUY | 181 @ USD 3.15 | USD 570 | The ETF bought 181 new shares of RCKT (Rocket Pharmaceuticals Inc). The shares were bought for an average price of 3.15 compared to the previous average buy price of 5.21303. This is -39.6% lower than average price of previous purchases of RCKT. |
| ACIU - AC Immune Ltd | BUY | 169 @ USD 3.35 | USD 566 | The ETF bought 169 new shares of ACIU (AC Immune Ltd). The shares were bought for an average price of 3.35 compared to the previous average buy price of 2.38505. This is 40.5% higher than average price of previous purchases of ACIU. |
| LYEL - Lyell Immunopharma Inc | BUY | 32 @ USD 17.68 | USD 566 | The ETF bought 32 new shares of LYEL (Lyell Immunopharma Inc). The shares were bought for an average price of 17.68 compared to the previous average buy price of 3.96367. This is 346.1% higher than average price of previous purchases of LYEL. |
| BCYC - Bicycle Therapeutics Ltd | BUY | 80 @ USD 6.58001 | USD 526 | The ETF bought 80 new shares of BCYC (Bicycle Therapeutics Ltd). The shares were bought for an average price of 6.58001 compared to the previous average buy price of 8.60328. This is -23.5% lower than average price of previous purchases of BCYC. |
| TRDA - Entrada Therapeutics Inc | BUY | 69 @ USD 7.26001 | USD 501 | The ETF bought 69 new shares of TRDA (Entrada Therapeutics Inc). The shares were bought for an average price of 7.26001 compared to the previous average buy price of 7.65435. This is -5.2% lower than average price of previous purchases of TRDA. |
| AUTL - Autolus Therapeutics Ltd | BUY | 370 @ USD 1.32 | USD 488 | The ETF bought 370 new shares of AUTL (Autolus Therapeutics Ltd). The shares were bought for an average price of 1.32 compared to the previous average buy price of 1.84388. This is -28.4% lower than average price of previous purchases of AUTL. |
| VNDA - Vanda Pharmaceuticals Inc | BUY | 109 @ USD 4.41999 | USD 482 | The ETF bought 109 new shares of VNDA (Vanda Pharmaceuticals Inc). The shares were bought for an average price of 4.41999 compared to the previous average buy price of 4.85747. This is -9.0% lower than average price of previous purchases of VNDA. |
| AVIR - Atea Pharmaceuticals Inc | BUY | 143 @ USD 3.33 | USD 476 | The ETF bought 143 new shares of AVIR (Atea Pharmaceuticals Inc). The shares were bought for an average price of 3.33 compared to the previous average buy price of 3.32765. This is 0.1% higher than average price of previous purchases of AVIR. |
| ALLO - Allogene Therapeutics Inc | BUY | 374 @ USD 1.18 | USD 441 | The ETF bought 374 new shares of ALLO (Allogene Therapeutics Inc). The shares were bought for an average price of 1.18 compared to the previous average buy price of 1.33815. This is -11.8% lower than average price of previous purchases of ALLO. |
| ARCT - Arcturus Therapeutics Holdings Inc | BUY | 48 @ USD 8.78 | USD 421 | The ETF bought 48 new shares of ARCT (Arcturus Therapeutics Holdings Inc). The shares were bought for an average price of 8.78 compared to the previous average buy price of 14.828. This is -40.8% lower than average price of previous purchases of ARCT. |
| EDIT - Editas Medicine Inc | BUY | 164 @ USD 2.51999 | USD 413 | The ETF bought 164 new shares of EDIT (Editas Medicine Inc). The shares were bought for an average price of 2.51999 compared to the previous average buy price of 2.74932. This is -8.3% lower than average price of previous purchases of EDIT. |
| HUMA - Humacyte Inc | BUY | 280 @ USD 1.35 | USD 378 | The ETF bought 280 new shares of HUMA (Humacyte Inc). The shares were bought for an average price of 1.35 compared to the previous average buy price of 2.22786. This is -39.4% lower than average price of previous purchases of HUMA. |
| VYGR - Voyager Therapeutics Inc | BUY | 88 @ USD 4.26 | USD 375 | The ETF bought 88 new shares of VYGR (Voyager Therapeutics Inc). The shares were bought for an average price of 4.26 compared to the previous average buy price of 3.8543. This is 10.5% higher than average price of previous purchases of VYGR. |
| OABI - OmniAb Inc. | BUY | 213 @ USD 1.49 | USD 317 | The ETF bought 213 new shares of OABI (OmniAb Inc.). The shares were bought for an average price of 1.49 compared to the previous average buy price of 1.92012. This is -22.4% lower than average price of previous purchases of OABI. |
| MXCT - MaxCyte Inc | BUY | 184 @ USD 1.47 | USD 270 | The ETF bought 184 new shares of MXCT (MaxCyte Inc). The shares were bought for an average price of 1.47 compared to the previous average buy price of 2.19832. This is -33.1% lower than average price of previous purchases of MXCT. |
| ALEC - Alector Inc | BUY | 182 @ USD 1.30999 | USD 238 | The ETF bought 182 new shares of ALEC (Alector Inc). The shares were bought for an average price of 1.30999 compared to the previous average buy price of 1.95849. This is -33.1% lower than average price of previous purchases of ALEC. |
| FATE - Fate Therapeutics Inc | BUY | 187 @ USD 1.08999 | USD 204 | The ETF bought 187 new shares of FATE (Fate Therapeutics Inc). The shares were bought for an average price of 1.08999 compared to the previous average buy price of 1.19552. This is -8.8% lower than average price of previous purchases of FATE. |
| BMEA - Biomea Fusion Inc | BUY | 119 @ USD 1.37 | USD 163 | The ETF bought 119 new shares of BMEA (Biomea Fusion Inc). The shares were bought for an average price of 1.37 compared to the previous average buy price of 1.82675. This is -25.0% lower than average price of previous purchases of BMEA. |
| PLRX - Pliant Therapeutics Inc | BUY | 100 @ USD 1.61999 | USD 162 | The ETF bought 100 new shares of PLRX (Pliant Therapeutics Inc). The shares were bought for an average price of 1.61999 compared to the previous average buy price of 1.49619. This is 8.3% higher than average price of previous purchases of PLRX. |
| MGNX - MacroGenics Inc | BUY | 106 @ USD 1.42999 | USD 152 | The ETF bought 106 new shares of MGNX (MacroGenics Inc). The shares were bought for an average price of 1.42999 compared to the previous average buy price of 1.58167. This is -9.6% lower than average price of previous purchases of MGNX. |
| STRO - Sutro Biopharma | BUY | 135 @ USD 0.806108 | USD 109 | The ETF bought 135 new shares of STRO (Sutro Biopharma). The shares were bought for an average price of 0.806108 compared to the previous average buy price of 0.904658. This is -10.9% lower than average price of previous purchases of STRO. |
| MRSN - Mersana Therapeutics Inc | BUY | 8 @ USD 8.61016 | USD 69 | The ETF bought 8 new shares of MRSN (Mersana Therapeutics Inc). The shares were bought for an average price of 8.61016 compared to the previous average buy price of 0.522006. This is 1,549.4% higher than average price of previous purchases of MRSN. |
| OKUR - OKUR | BUY | 21 @ USD 3.06994 | USD 64 | The ETF bought 21 new shares of OKUR (OKUR). The shares were bought for an average price of 3.06994 compared to the previous average buy price of 6.18362. This is -50.4% lower than average price of previous purchases of OKUR. |
| - - | HOLD | 0 @ USD 0 | USD 0 | |
| COGT - Cogent Biosciences Inc | HOLD | 0 @ USD 32.46 | USD 0 | The current share valuation price of COGT based on adjusted close was USD 32.46. The average price that COGT shares were previous bought at was USD 9.72589. The current market price is 233.7% higher than average price they were purchased at. The value of the holding in COGT has increased by USD 1,576,928 compared to the previous valuation of Cogent Biosciences Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| IRWD - Ironwood Pharmaceuticals Inc | HOLD | 0 @ USD 2.53 | USD 0 | The current share valuation price of IRWD based on adjusted close was USD 2.53. The average price that IRWD shares were previous bought at was USD 1.13295. The current market price is 123.3% higher than average price they were purchased at. The value of the holding in IRWD has increased by USD 59,736 compared to the previous valuation of Ironwood Pharmaceuticals Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| THRD - Third Harmonic Bio Inc. | HOLD | 0 @ USD 0.0300173 | USD 0 | The current share valuation price of THRD based on adjusted close was USD 0.0300173. The average price that THRD shares were previous bought at was USD 5.04749. The current market price is -99.4% lower than average price they were purchased at. USD 0 compared to the previous valuation of Third Harmonic Bio Inc. however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |